TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
UPSC | Exam ScheduleExam Mentor
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | ChinaUnited StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
News Columns | Straight DriveCanada CallingLondon LetterKashmir AngleJammu JournalInside the CapitalHimachal CallingHill View
Don't Miss
Advertisement

Hectic buying propels market rally for 4th day; Sensex up 1%

BSE benchmark reclaims 76K mark
File

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

Driven by across-the-board buying amid a mixed trend in global equities after the US Federal Reserve maintained its rate cut projections for this year, stock market benchmarks Sensex and Nifty continued their rising streak for the fourth straight session and climbed over 1 per cent on Thursday.

Advertisement

According to market experts, the investor sentiment was boosted by hectic buying in market heavyweights Reliance Industries, Bharti Airtel and IT stocks.

Advertisement

Regaining the 76,000 level, the 30-share BSE benchmark Sensex soared 899.01 points or 1.19 per cent to settle at 76,348.06. It climbed 1,007.2 points or 1.33 per cent to 76,456.25 during the day.

To reclaim the 23,000-mark, the NSE Nifty rose 283.05 points or 1.24 per cent and closed at 23,190.65.

Among the major gainers from the Sensex pack were Bharti Airtel, Titan, Tata Consultancy Services, Hindustan Unilever, Infosys, Nestle, Reliance Industries, Mahindra & Mahindra, HDFC Bank and Tata Motors while IndusInd Bank, Bajaj Finance and UltraTech Cement remained the losers.

Advertisement

Advertisement
Show comments
Advertisement